oxotremorine m has been researched along with Alloxan Diabetes in 2 studies
oxotremorine M: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, L | 1 |
| He, F | 1 |
| Huang, M | 1 |
| Zhao, Q | 1 |
| Cheng, L | 1 |
| Said, N | 1 |
| Zhou, Z | 1 |
| Liu, F | 1 |
| Dai, YS | 1 |
| Pak, KJ | 1 |
| Ostrom, RS | 1 |
| Matsui, M | 1 |
| Ehlert, FJ | 1 |
2 other studies available for oxotremorine m and Alloxan Diabetes
| Article | Year |
|---|---|
SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells.
Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Glucose Intolerance; Humans; Insulin; Insulin Sec | 2020 |
Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.
Topics: Animals; Colforsin; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mice; Mice, Inbre | 2010 |